Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

The following table summarizes the Company’s stock option activity since December 31, 2022:


	Number of Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2022	4,034,287	$	6.90	6.9	$	1,625
Granted	—	$	—
Exercised	(7,978)	$	3.92
Cancelled/Forfeited	(3,271)	$	7.89
Outstanding as of March 31, 2023	4,023,038	$	6.90	6.6	$	91
Options exercisable as of March 31, 2023	2,506,800	$	5.86	5.5	$	91
Options vested and expected to vest as of March 31, 2023	4,023,038	$	6.90	6.6	$	91

Restricted stock units activity

The following table summarizes the activity related to the Company's restricted stock units:


	Outstanding Restricted Stock Units	Weighted- Average Grant Date Fair Value
Outstanding as of December 31, 2022	2,807,981	$	7.85
Granted	2,487,455	4.00
Vested	(241,175)	8.39
Cancelled	(10,433)	8.36
Outstanding as of March 31, 2023	5,043,828	$	5.92

Classification of stock-based compensation

The following table summarizes the classification of the Company’s stock-based compensation expense in the condensed consolidated statements of operations:


(in thousands)	Three Months Ended March 31,
	2023		2022
Cost of revenue	$	149	$	83
Sales and marketing	707		301
Technology development	1,051		432
General and administrative	1,199		529
Total stock-based compensation expense	$	3,106	$	1,345